Midland Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
1,638
-66
-4% -$67.4K 0.09% 47
2026
Q1
$1.57M Sell
1,704
-55
-3% -$55.8K 0.08% 55
2025
Q4
$1.89M Sell
1,759
-449
-20% -$429K 0.1% 45
2025
Q3
$1.68M Sell
2,208
-644
-23% -$479K 0.09% 56
2025
Q2
$2.22M Sell
2,852
-121
-4% -$94K 0.12% 40
2025
Q1
$2.46M Sell
2,973
-164
-5% -$136K 0.14% 38
2024
Q4
$2.42M Sell
3,137
-130
-4% -$108K 0.15% 42
2024
Q3
$2.89M Sell
3,267
-489
-13% -$440K 0.17% 34
2024
Q2
$3.4M Sell
3,756
-26
-0.7% -$20.8K 0.2% 31
2024
Q1
$2.94M Sell
3,782
-403
-10% -$287K 0.18% 30
2023
Q4
$2.44M Buy
+4,185
New +$2.44M 0.17% 33

Other funds holding LLY

Midland Wealth Advisors's LLY Position: Q2 2026 in Review

Midland Wealth Advisors reduced its Eli Lilly (LLY) stake by 3.9% in Q2 2026, selling an estimated $67.4K and leaving 1,638 shares worth $1.96M. The position accounts for 0.09% of the portfolio, ranked #47.

Midland Wealth Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.4M in Q2 2024. 1,962 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Midland Wealth Advisors held 1,638 shares of Eli Lilly worth $1.96M as of Q2 2026.
  • Midland Wealth Advisors sold 66 Eli Lilly shares in Q2 2026, an estimated $67.4K.
  • Eli Lilly made up 0.09% of Midland Wealth Advisors's portfolio in Q2 2026, its #47 holding.
  • Midland Wealth Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Midland Wealth Advisors's Eli Lilly position peaked at $3.4M in Q2 2024.
  • 1,962 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Midland Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.